Press Releases< /span>
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 7, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has enrolled the first patient in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of...
-
Aug 31, 2009
Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer of the Company, is presenting at Rodman & Renshaw's 11th Annual Healthcare...
-
Jul 29, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2009.Q2 2009 Summary --------------- - Finalized FDA...
-
Jul 20, 2009
- Second quarter financial results to be released July 29, 2009 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 20 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a conference...
-
May 13, 2009
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2009.Q1 2009 Summary ---------------- - Received tentative U.S....